Manufacturing in today’s life sciences and health technologies space presents unique challenges, not to mention the opportunity to make a major impact. For example, the recruitment of talent in a GMP compliant environment has proven critical to support Canada’s efforts to fight the COVID-19 pandemic, helping to start up entirely new biologics manufacturing facilities.
As we look to continue to improve our collective response to epidemics, ensure the supply of vaccines, and advance the science that governs product development on a national scale, definitive leadership in manufacturing will guide the success of critical health initiatives.
Our team is proud to have helped bring together the brightest minds in LHST to build manufacturing teams leading daily operations of biologics and vaccines in accordance with GMP standards and critical times in Canada. At Pender & Howe, we continue to lead the executive search process to drive manufacturing, quality, regulatory affairs, facilities engineering, and supply chain teams forward in these organizations.